Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,200
Closed -$901K 843
2021
Q1
$901K Buy
11,200
+2,400
+27% +$183K 0.01% 1022
2020
Q4
$552K Buy
+8,800
New +$502K ﹤0.01% 1231
2020
Q2
Sell
-74,600
Closed -$1.27M 1480
2020
Q1
$1.27M Sell
74,600
-7,000
-9% -$223K 0.01% 861
2019
Q4
$3.42M Buy
81,600
+70,100
+610% +$2.45M 0.02% 649
2019
Q3
$319K Buy
+11,500
New +$279K ﹤0.01% 1330
2019
Q2
Sell
-63,262
Closed -$1.63M 1417
2019
Q1
$1.63M Buy
63,262
+10,200
+19% +$279K 0.01% 792
2018
Q4
$1.38M Sell
53,062
-74,938
-59% -$1.75M 0.01% 812
2018
Q3
$2.73M Sell
128,000
-126,600
-50% -$2.43M 0.02% 623
2018
Q2
$4.48M Sell
254,600
-56,700
-18% -$965K 0.03% 509
2018
Q1
$5.06M Buy
+311,300
New +$4.32M 0.03% 500

Other funds holding CROX

Mackay Shields LLC's CROX Position: Q2 2021 in Review

Mackay Shields LLC sold out of Crocs (CROX) in Q2 2021, closing a stake of 11,200 shares — an estimated $901K sold.

Mackay Shields LLC first reported a position in CROX in Q1 2018 and held it in 10 quarters. The position peaked at $5.06M in Q1 2018. 348 funds tracked by Wall St. Rank hold CROX as of Q2 2021.

  • Mackay Shields LLC reported no remaining Crocs position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 11,200 Crocs shares in Q2 2021, an estimated $901K.
  • Mackay Shields LLC first reported a position in Crocs in Q1 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Crocs position peaked at $5.06M in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Crocs as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.